Nature:基于长读长测序的等位基因特异性分析揭示人类组织转录组变异

2022-08-31 测序中国 测序中国

研究团队开发了一个新的计算软件包LORALS,通过长读长测序等位基因特异性分析来研究罕见和常见变异对转录组的遗传影响,同时描述了等位基因特异性表达和转录本结构事件。

RNA剪接导致的转录结构变化以及5 '3 '非翻译区(UTRs)的差异是基因调控的一个关键特征。转录结构的破坏在人类疾病中起着重要作用,与剪接变化相关的遗传变异涉及常见疾病及许多严重的孟德尔病。通过转录比率数量性状位点(trQTL)和剪接数量性状位点(sQTL)分析可以绘制出影响转录组结构的常见遗传变异,进一步表明影响基因表达水平和剪接的遗传变异往往是不同的。

用于分析遗传调控效应的正交方法——等位基因特异性表达(ASE)分析,已被证明是研究罕见遗传变异的一种高度敏感方法。目前,长读长RNA测序技术已经被用于研究转录组结构和新转录足,以及早期等位基因特异性分析。因此,通过长读长转录组数据进行等位基因特异性转录结构(AST)分析,可以提供关于罕见和常见变异如何影响转录结构和疾病风险的重要信息。

近日,来自美国纽约哥伦比亚大学的研究团队通过长读长等位基因特异性分析来了解罕见和常见变异对转录组的遗传影响。该研究结果发表Nature上,文章题为“Transcriptome variation in human tissues revealed by long-read sequencing”

图片

文章发表在Nature

研究团队利用ONT平台,对GTEx项目的细胞系和人体组织的88个样本进行了长读长RNA-seq。分析显示,长读长测序数据的基因和转录组定量与Illumina RNA-seq高度一致。低相关性基因和转录组在ONT数据中表达较低,复杂性较高的基因和转录组包含多个外显子。(图1)研究团队分析了一些相关性较低的基因阅读覆盖率,例如PRELID1ONT捕捉得更好;ARSBONT测序显示3 '偏倚。

图片

1.数据集概述和质量控制。

研究团队使用FLAIR31量化了转录组并识别新转录组。更多的新转录组在注释转录组数量高的基因中被发现(图2),87%内含子保留事件为新发现,表明虽然已进行了polya)富集步骤,但pre-mRNA仍然存在。另一方面,只有37%的外显子跳过事件是新发现的,表明它们在现有的注释中得到了更好的表达。

图片

2.新转录本的发现和组织间的比较。

接下来,为了解决由相关位点附近的测序错误导致的局部比对偏差,研究团队开发了一个比对框架,并为每个供体创建了两个单倍型特异性参考。为了进行ASEAST分析,研究团队对比了一个转录组相对于同一基因的其他转录组(图3),研究团队开发了一个新的软件包LORALS(长读长等位基因分析)。除了采用以前为短读长测序数据开发的可映射性和基因分型错误过滤器,研究团队还引入了处理长读长测序数据较高错误率的标记,并使用模拟数据进行了功率计算,以测试reads、转录组数量和效应大小如何影响AST检测能力。

图片

3.长读长测序数据的等位基因分析。

最后,研究团队评估了用新颖的转录注释和来自长读长测序的AST数据更好地解释罕见变异的潜力。评估结果显示,产生最严重后果的变异占所有变异的0.75%,其中编码变异为16435个。研究发现,与保留相同注释的变体相比,重新分配给更严重后果的变体平均具有更高的CADD得分(图4)。被重新分配为致病性变异的结果表明,该研究检测出了以前可能被遗漏的部分生物学和功能性变异。因此,研究团队重新注释了ClinVar变体,最终9582个变体重新分配(1.23%)。研究发现,不确定的良性或致病性临床意义且没有认定标准的变异被重新分配的比例最高(4%3.1%)。

图片

4.通过新发现转录组和AST分析的变体解释。

综上所述,研究团队开发了一个新的计算软件包LORALS,通过长读长测序等位基因特异性分析来研究罕见和常见变异对转录组的遗传影响。研究团队描述了等位基因特异性表达和转录本结构事件,为常见和罕见基因变异引起的特定转录组改变提供了新的见解。以上结果加强了人们对转录组分析重要性的认识,即不是从基因或不精确定义的剪接水平上分析,而是对特定转录本的详细描述。

参考资料:

Glinos, D.A., Garborcauskas, G., Hoffman, P. et al. Transcriptome variation in human tissues revealed by long-read sequencing. Nature 608, 353–359 (2022). https://doi.org/10.1038/s41586-022-05035-y

https://www.nature.com/articles/s41586-022-05035-y

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1886008, encodeId=16121886008f6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 19 06:15:38 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899585, encodeId=09d4189958528, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Apr 02 13:15:38 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126922, encodeId=6e2d212692280, content=已经认真学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55488636654, createdName=ms5000000159272953, createdTime=Tue Apr 18 23:37:49 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1747468, encodeId=a3e81e47468e4, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Feb 05 12:15:38 CST 2023, time=2023-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992004, encodeId=57ca1992004b8, content=<a href='/topic/show?id=d4f0e5890e9' target=_blank style='color:#2F92EE;'>#等位基因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75890, encryptionId=d4f0e5890e9, topicName=等位基因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue May 30 10:15:38 CST 2023, time=2023-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343065, encodeId=c4e51343065ee, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420237, encodeId=8ed8142023ef3, content=<a href='/topic/show?id=5f3a9336904' target=_blank style='color:#2F92EE;'>#转录组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93369, encryptionId=5f3a9336904, topicName=转录组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9e3571203, createdName=marlenexl, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484170, encodeId=266f14841e03f, content=<a href='/topic/show?id=d2fbe588905' target=_blank style='color:#2F92EE;'>#等位基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75889, encryptionId=d2fbe588905, topicName=等位基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e17955541, createdName=luckyshitiancai_42705686, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2022-10-19 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1886008, encodeId=16121886008f6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 19 06:15:38 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899585, encodeId=09d4189958528, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Apr 02 13:15:38 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126922, encodeId=6e2d212692280, content=已经认真学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55488636654, createdName=ms5000000159272953, createdTime=Tue Apr 18 23:37:49 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1747468, encodeId=a3e81e47468e4, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Feb 05 12:15:38 CST 2023, time=2023-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992004, encodeId=57ca1992004b8, content=<a href='/topic/show?id=d4f0e5890e9' target=_blank style='color:#2F92EE;'>#等位基因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75890, encryptionId=d4f0e5890e9, topicName=等位基因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue May 30 10:15:38 CST 2023, time=2023-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343065, encodeId=c4e51343065ee, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420237, encodeId=8ed8142023ef3, content=<a href='/topic/show?id=5f3a9336904' target=_blank style='color:#2F92EE;'>#转录组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93369, encryptionId=5f3a9336904, topicName=转录组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9e3571203, createdName=marlenexl, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484170, encodeId=266f14841e03f, content=<a href='/topic/show?id=d2fbe588905' target=_blank style='color:#2F92EE;'>#等位基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75889, encryptionId=d2fbe588905, topicName=等位基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e17955541, createdName=luckyshitiancai_42705686, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1886008, encodeId=16121886008f6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 19 06:15:38 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899585, encodeId=09d4189958528, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Apr 02 13:15:38 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126922, encodeId=6e2d212692280, content=已经认真学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55488636654, createdName=ms5000000159272953, createdTime=Tue Apr 18 23:37:49 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1747468, encodeId=a3e81e47468e4, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Feb 05 12:15:38 CST 2023, time=2023-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992004, encodeId=57ca1992004b8, content=<a href='/topic/show?id=d4f0e5890e9' target=_blank style='color:#2F92EE;'>#等位基因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75890, encryptionId=d4f0e5890e9, topicName=等位基因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue May 30 10:15:38 CST 2023, time=2023-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343065, encodeId=c4e51343065ee, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420237, encodeId=8ed8142023ef3, content=<a href='/topic/show?id=5f3a9336904' target=_blank style='color:#2F92EE;'>#转录组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93369, encryptionId=5f3a9336904, topicName=转录组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9e3571203, createdName=marlenexl, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484170, encodeId=266f14841e03f, content=<a href='/topic/show?id=d2fbe588905' target=_blank style='color:#2F92EE;'>#等位基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75889, encryptionId=d2fbe588905, topicName=等位基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e17955541, createdName=luckyshitiancai_42705686, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2023-04-18 ms5000000159272953 来自广东省

    已经认真学习了啊

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1886008, encodeId=16121886008f6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 19 06:15:38 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899585, encodeId=09d4189958528, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Apr 02 13:15:38 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126922, encodeId=6e2d212692280, content=已经认真学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55488636654, createdName=ms5000000159272953, createdTime=Tue Apr 18 23:37:49 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1747468, encodeId=a3e81e47468e4, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Feb 05 12:15:38 CST 2023, time=2023-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992004, encodeId=57ca1992004b8, content=<a href='/topic/show?id=d4f0e5890e9' target=_blank style='color:#2F92EE;'>#等位基因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75890, encryptionId=d4f0e5890e9, topicName=等位基因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue May 30 10:15:38 CST 2023, time=2023-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343065, encodeId=c4e51343065ee, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420237, encodeId=8ed8142023ef3, content=<a href='/topic/show?id=5f3a9336904' target=_blank style='color:#2F92EE;'>#转录组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93369, encryptionId=5f3a9336904, topicName=转录组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9e3571203, createdName=marlenexl, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484170, encodeId=266f14841e03f, content=<a href='/topic/show?id=d2fbe588905' target=_blank style='color:#2F92EE;'>#等位基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75889, encryptionId=d2fbe588905, topicName=等位基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e17955541, createdName=luckyshitiancai_42705686, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2023-02-05 mjldent
  5. [GetPortalCommentsPageByObjectIdResponse(id=1886008, encodeId=16121886008f6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 19 06:15:38 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899585, encodeId=09d4189958528, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Apr 02 13:15:38 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126922, encodeId=6e2d212692280, content=已经认真学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55488636654, createdName=ms5000000159272953, createdTime=Tue Apr 18 23:37:49 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1747468, encodeId=a3e81e47468e4, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Feb 05 12:15:38 CST 2023, time=2023-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992004, encodeId=57ca1992004b8, content=<a href='/topic/show?id=d4f0e5890e9' target=_blank style='color:#2F92EE;'>#等位基因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75890, encryptionId=d4f0e5890e9, topicName=等位基因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue May 30 10:15:38 CST 2023, time=2023-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343065, encodeId=c4e51343065ee, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420237, encodeId=8ed8142023ef3, content=<a href='/topic/show?id=5f3a9336904' target=_blank style='color:#2F92EE;'>#转录组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93369, encryptionId=5f3a9336904, topicName=转录组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9e3571203, createdName=marlenexl, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484170, encodeId=266f14841e03f, content=<a href='/topic/show?id=d2fbe588905' target=_blank style='color:#2F92EE;'>#等位基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75889, encryptionId=d2fbe588905, topicName=等位基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e17955541, createdName=luckyshitiancai_42705686, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1886008, encodeId=16121886008f6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 19 06:15:38 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899585, encodeId=09d4189958528, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Apr 02 13:15:38 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126922, encodeId=6e2d212692280, content=已经认真学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55488636654, createdName=ms5000000159272953, createdTime=Tue Apr 18 23:37:49 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1747468, encodeId=a3e81e47468e4, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Feb 05 12:15:38 CST 2023, time=2023-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992004, encodeId=57ca1992004b8, content=<a href='/topic/show?id=d4f0e5890e9' target=_blank style='color:#2F92EE;'>#等位基因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75890, encryptionId=d4f0e5890e9, topicName=等位基因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue May 30 10:15:38 CST 2023, time=2023-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343065, encodeId=c4e51343065ee, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420237, encodeId=8ed8142023ef3, content=<a href='/topic/show?id=5f3a9336904' target=_blank style='color:#2F92EE;'>#转录组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93369, encryptionId=5f3a9336904, topicName=转录组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9e3571203, createdName=marlenexl, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484170, encodeId=266f14841e03f, content=<a href='/topic/show?id=d2fbe588905' target=_blank style='color:#2F92EE;'>#等位基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75889, encryptionId=d2fbe588905, topicName=等位基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e17955541, createdName=luckyshitiancai_42705686, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1886008, encodeId=16121886008f6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 19 06:15:38 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899585, encodeId=09d4189958528, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Apr 02 13:15:38 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126922, encodeId=6e2d212692280, content=已经认真学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55488636654, createdName=ms5000000159272953, createdTime=Tue Apr 18 23:37:49 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1747468, encodeId=a3e81e47468e4, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Feb 05 12:15:38 CST 2023, time=2023-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992004, encodeId=57ca1992004b8, content=<a href='/topic/show?id=d4f0e5890e9' target=_blank style='color:#2F92EE;'>#等位基因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75890, encryptionId=d4f0e5890e9, topicName=等位基因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue May 30 10:15:38 CST 2023, time=2023-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343065, encodeId=c4e51343065ee, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420237, encodeId=8ed8142023ef3, content=<a href='/topic/show?id=5f3a9336904' target=_blank style='color:#2F92EE;'>#转录组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93369, encryptionId=5f3a9336904, topicName=转录组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9e3571203, createdName=marlenexl, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484170, encodeId=266f14841e03f, content=<a href='/topic/show?id=d2fbe588905' target=_blank style='color:#2F92EE;'>#等位基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75889, encryptionId=d2fbe588905, topicName=等位基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e17955541, createdName=luckyshitiancai_42705686, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1886008, encodeId=16121886008f6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 19 06:15:38 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899585, encodeId=09d4189958528, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Apr 02 13:15:38 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126922, encodeId=6e2d212692280, content=已经认真学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55488636654, createdName=ms5000000159272953, createdTime=Tue Apr 18 23:37:49 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1747468, encodeId=a3e81e47468e4, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Feb 05 12:15:38 CST 2023, time=2023-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992004, encodeId=57ca1992004b8, content=<a href='/topic/show?id=d4f0e5890e9' target=_blank style='color:#2F92EE;'>#等位基因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75890, encryptionId=d4f0e5890e9, topicName=等位基因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue May 30 10:15:38 CST 2023, time=2023-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343065, encodeId=c4e51343065ee, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420237, encodeId=8ed8142023ef3, content=<a href='/topic/show?id=5f3a9336904' target=_blank style='color:#2F92EE;'>#转录组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93369, encryptionId=5f3a9336904, topicName=转录组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9e3571203, createdName=marlenexl, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484170, encodeId=266f14841e03f, content=<a href='/topic/show?id=d2fbe588905' target=_blank style='color:#2F92EE;'>#等位基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75889, encryptionId=d2fbe588905, topicName=等位基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68e17955541, createdName=luckyshitiancai_42705686, createdTime=Fri Sep 02 06:15:38 CST 2022, time=2022-09-02, status=1, ipAttribution=)]

相关资讯

Circulation:APOL1风险等位基因与心血管疾病的相关性

约13%的黑种人携带2个拷贝的载脂蛋白L1(APOL1)风险等位基因G1或G2,与慢性肾病风险增加1.5-2.5倍相关。关于APOL1风险等位基因与心血管疾病(CVD)之间是否存在独立于APOL1对肾脏疾病的影响之外的关联,一直存在相互矛盾的报道。现研究人员对APOL1 G1/G2等位基因与黑人冠状动脉疾病、外周血管病和卒中的相关性进行评估。研究人员对电子健康病例进行回顾性分析。主要暴露是APOL

ARD: 对IL-1和IL-6抑制剂的严重迟发性超敏反应与常见的HLA-DRB1*15等位基因有关

该研究分析了人类白细胞抗原(HLA)等位基因与IL-1/IL-6抑制剂相关迟发型超敏反应的关联。

Nat Med:特异性等位基因编辑能够预防耳聋

由于大多数人类的变异均为单核苷酸替换,最近,有研究人员探索了基因编辑策略来干扰显性变异效果,并选择性的避开对野生型等位基因的影响。然而,当前常用的内切酶比如酿脓链球菌Cas9(SpCas9)能够接受向导RNA(gRNA)和靶标RNA之间多达7个核苷酸的差异,因而很难做到对单个核苷酸的区分。更多的是,前间区序列邻近基序(PAM)在一些Cas9酶中也能够接受与靶DNA的错配情况。最近,有研究人员为了克

J Ophthalmol:巴西艾滋病患者的HLA-C等位基因和巨细胞病毒性视网膜炎研究调查

巴西圣保罗圣保罗大学Ribeirao Preto医学院眼科的Biberg-Salum TG等近日在J Ophthalmol杂志上发表了一篇重要的工作。由于巨细胞病毒视网膜炎(CR)是艾滋病患者视力损害的重要原因,并且HLA-C等位基因与AIDS疾病发生发展相关,因此,他们在患有或CR携带者的AIDS患者中对HLA-C基因座进行筛查研究。

Nature Genetics:DeepLoop:利用低深度Hi-C数据绘制人类基因组等位基因特异性染色质互作图谱

研究团队开发了DeepLoop,执行严格的偏差校正,通过基于深度学习的信号增强,从低深度Hi-C数据中实现稳健的染色质相互作用映射。

Diabetic Med: 采用11个易感等位基因对普通日本人群中2型糖尿病发病率的遗传风险评分的预测性能如何?

近日,国际杂志 《Diabetic Med》上在线发表一项关于使用11个易感等位基因对普通日本人群中2型糖尿病发病率的遗传风险评分的预测性能的巢式病例对照研究,以评估遗传风险评分对一般日本人群中2型糖尿病发病率的预测能力。 这项前瞻性病例对照研结合在在日本公共卫生中心的前瞻性研究中,其中包括466名5年期间患有2型糖尿病的病例(病例)和1361名对照参与者,以及1463名现有糖尿病患者和14